| Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial R Ella, S Reddy, W Blackwelder, V Potdar, P Yadav, V Sarangi, VK Aileni, ... The Lancet 398 (10317), 2173-2184, 2021 | 352 | 2021 |
| Strong and weak hydrogen bonds in the protein–ligand interface SK Panigrahi, GR Desiraju Proteins: Structure, Function, and Bioinformatics 67 (1), 128-141, 2007 | 249 | 2007 |
| Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study SK Panigrahi Amino Acids 34, 617-633, 2008 | 76 | 2008 |
| HBAT: a complete package for analysing strong and weak hydrogen bonds in macromolecular crystal structures A Tiwari, SK Panigrahi In silico biology 7 (6), 651-661, 2007 | 72 | 2007 |
| Virtual screening of 4-anilinoquinazoline analogues as EGFR kinase inhibitors: importance of hydrogen bonds in the evaluation of poses and scoring functions V Aparna, G Rambabu, SK Panigrahi, J Sarma, GR Desiraju Journal of chemical information and modeling 45 (3), 725-738, 2005 | 57 | 2005 |
| Strong and weak hydrogen bonds in drug-DNA complexes: a statistical analysis SK Panigrahi, GR Desiraju Journal of biosciences 32, 677-691, 2007 | 56 | 2007 |
| Design of EGFR kinase inhibitors: a ligand-based approach and its confirmation with structure-based studies A Vema, SK Panigrahi, G Rambabu, B Gopalakrishnan, J Sarma, ... Bioorganic & medicinal chemistry 11 (21), 4643-4653, 2003 | 40 | 2003 |
| Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors M Takhi, K Sreenivas, CK Reddy, M Munikumar, K Praveena, P Sudheer, ... European journal of medicinal chemistry 84, 382-394, 2014 | 33 | 2014 |
| Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild type and mutant (L1196M) active compounds with unique binding mode VR Gummadi, S Rajagopalan, CY Looi, M Paydar, GA Renukappa, ... Bioorganic & medicinal chemistry letters 23 (17), 4911-4918, 2013 | 33 | 2013 |
| Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors AP Chandrasekharappa, SE Badiger, PK Dubey, SK Panigrahi, ... Bioorganic & medicinal chemistry letters 23 (9), 2579-2584, 2013 | 26 | 2013 |
| X-ray structure of PTP1B in complex with a new PTP1B inhibitor C Ghadiyaram, S Kumar Panigrahi, N Rao Krishnamurthy, S Hosahalli, ... Protein and Peptide Letters 21 (1), 90-93, 2014 | 22 | 2014 |
| Selective vulnerability to pyrimidine starvation in hematologic malignancies revealed by AG-636, a novel clinical-stage inhibitor of dihydroorotate dehydrogenase G McDonald, V Chubukov, J Coco, K Truskowski, R Narayanaswamy, ... Molecular Cancer Therapeutics 19 (12), 2502-2515, 2020 | 18 | 2020 |
| Selective PPARδ modulators improve mitochondrial function: potential treatment for duchenne muscular dystrophy (DMD) B Lagu, AF Kluge, E Tozzo, R Fredenburg, EL Bell, MM Goddeeris, ... ACS medicinal chemistry letters 9 (9), 935-940, 2018 | 18 | 2018 |
| COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK MG BOCK, H MOEBITZ, SK PANIGRAHI, R PODDUTOORI, S SAMAJDAR WO Patent WO/2015/022,663, 2015 | 18 | 2015 |
| COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK MG BOCK, H MOEBITZ, SK PANIGRAHI, R PODDUTOORI, S SAMAJDAR WO Patent WO/2015/022,664, 2015 | 18 | 2015 |
| COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK MG BOCK, H MOEBITZ, SK PANIGRAHI, R PODDUTOORI, S SAMAJDAR WO Patent WO2,015,022,662, 2015 | 18 | 2015 |
| Substituted quinazoline and pyrido-pyrimidine derivatives RA Smith, SK Thompson, S Hosahalli, M Bejugam, S Nanduri, ... US Patent 8,440,662, 2013 | 15 | 2013 |
| PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF M DOWNES, M EVANS, Ronald, A KLUGE, B LAGU, M MIURA, ... WO Patent WO/2017/062,468, 2017 | 14* | 2017 |
| Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing B Lagu, AF Kluge, RA Fredenburg, E Tozzo, RS Senaiar, M Jaleel, ... Bioorganic & Medicinal Chemistry Letters 27 (23), 5230-5234, 2017 | 11 | 2017 |
| PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF T BAIGA, M DOWNES, R EVANS, A KLUGE, B LAGU, M MIURA, ... WO Patent WO/2016/057,658, 2016 | 11* | 2016 |
Gautam DesirajuProfessor of Chemistry, Indian Institute of ScienceVerified email at iisc.ac.in
